Related Experiment Videos
Focal paroxysmal kinesigenic choreoathetosis
Journal of Neurology, Neurosurgery, and Psychiatry
|April 1, 1983
Summary
Paroxysmal kinesigenic choreoathetosis (PKC) attacks, whether focal or generalized, responded effectively to phenytoin treatment. This study reviews cases and literature on PKC, highlighting successful therapeutic outcomes.
Area of Science:
- Neurology
- Movement Disorders
Background:
- Paroxysmal kinesigenic choreoathetosis (PKC) is a rare neurological disorder characterized by sudden, brief episodes of involuntary movements.
- Understanding the triggers and treatment responses in PKC is crucial for patient management.
Observation:
- Three cases presented with focally induced unilateral attacks of PKC.
- One additional case experienced bilateral attacks exclusively.
- All described cases involved involuntary choreoathetoid movements triggered by sudden motion.
Findings:
- Phenytoin demonstrated significant efficacy in treating paroxysmal kinesigenic choreoathetosis across all reported cases.
- The study reviewed literature concerning both focal and generalized presentations of PKC.
Implications:
- Phenytoin is a viable therapeutic option for managing paroxysmal kinesigenic choreoathetosis.
- Further research into the pathophysiology of PKC may elucidate mechanisms underlying focal versus generalized attacks.